Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Houston-Based Oil & Gas Producer Sets Goal to Become Wholly Carbon Neutral

A Raymond James report considers both what it would take to achieve this and how doing so could uplift profitability in relation to the company's use of enhanced oil recovery. In an April 2 research note, analyst Pavel Molchanov guesstimated the potential profitability ...
Streetwise Reports | April 8, 2019 |

Another Repo Market Liquidity Injection for Gold Bulls to Cheer

Last Thursday, the New York Fed added more than $80 billion in fresh temporary liquidity to the financial markets. Move over folks, nothing to see here – but what does it mean for gold prices? Repo Crisis Is Not Over Last week on Thursday, the New York Fed added $83.1 ...
Arkadiusz Sieron | January 16, 2020 |

Will the Second Wave Trigger Rally in Gold?

The initial health crisis seems to be under control in many countries. But this is not the end of pandemic and many epidemiologist warn against the second wave of injections. We invite you to read our today’s article about the second wave of the new coronavirus...
Arkadiusz Sieron | June 19, 2020 |

Barrick Gold, Newmont, Blackrock Gold: Opportunities in the sloping market

First the central banks and now possibly a generous new US President Joe Biden - when it comes to reasons for rising prices, market commentators always find an explanation. But one thing is sure: most support measures or capital injections are bought with capital that has eith...
Nico Popp | October 9, 2020 |

Biopharma's LDL Cholesterol-Lowering Drug Emerges as 'Lead Stallion in Safety'

The interim study results for an in-progress trial evaluating this asset are discussed in a ROTH Capital Partners report. Beaker In a May 20 research report, ROTH Capital Partners analyst Yasmeen Rahimi reported that The Medicines Company's (MDCO:...
Streetwise Reports | May 30, 2019 |

Ocular Therapeutix Shares Climb More than 25% on Q4 Revenue and Phase 1 Wet AMD Clinical Data

Ocular Therapeutix shares set a new 52-week high price after the company reported preliminary FY/19 revenue results along with positive interim data from its Phase 1 clinical study of OTX-TKI for treatment of wet age-related macular degeneration. Ocular Ther...
Streetwise Reports | March 5, 2020 |

Arbutus Biopharma Trades 25% Higher on Phase 1 Hepatitis B Results

Shares of Arbutus Biopharma traded higher after the company reported significant and continuous reduction in HBsAg in 12 chronic hepatitis B subjects using 60 mg dosage of its AB-729 drug. Clinical-stage biopharmaceutical company Arbutus Biopharma Corp. (ABUS:NASD...
Streetwise Reports | May 20, 2020 |

What Does The Great Disconnect Imply for Gold?

It seems that global stock markets have disconnected from the fundamental reality. They have been rising since the end of March despite the collapsing economies and soaring unemployment. We invite you to read our today’s article about the Great Disconnect and f...
Arkadiusz Sieron | June 15, 2020 |

Analyst: G1 Minimizes the Carnage of Chemotherapy

ROTH Capital Partners initiates coverage on U.S. oncology biopharma G1 Therapeutics that is now filing an NDA. In a June 26 research note, analyst Tony Butler reported that ROTH Capital Partners initiated coverage on G1 Therapeutics Inc. (GTHX:NASDAQ) with a Buy ...
Streetwise Reports | July 2, 2020 |

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
Knox Henderson | March 20, 2024 |
1 2 3